Vidarabine monohydrate

Overview

Vidarabine monohydrate is a Purine nucleoside derivative and Antiviral agent. The triphosphate derivative of Vidarabine monohydrate competitively inhibits DNA polymerase, incorporates into the terminus of elongating DNA molecules, and interferes with the early steps of viral DNA synthesis. Vidarabine monohydrate inhibits the replication of herpes simplex virus, varicella-zoster virus, cytomegalovirus, Epstein-Barr virus and vaccinia virus, reduces viral shedding, and accelerates skin healing. Vidarabine monohydrate is metabolized to arabinosyl hypoxanthine, causes minimal impairment of corneal wound healing in rabbit models, and is associated with recurrence of herpes simplex encephalitis. Vidarabine monohydrate can be used in the research of herpetic keratoconjunctivitis, herpes simplex encephalitis, herpetic uveitis, and chronic active hepatitis associated with hepatitis B virus.

Application

Products | Products > Disease Areas > Infection | Products > Disease Areas > Viral Infection | Products > Disease Areas > Cytomegalovirus Infection | Products > Disease Areas > HSV Infection | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Infection | Products > Signaling Pathways > Nucleoside Antimetabolite/Analog | Products > Signaling Pathways > DNA/RNA Synthesis | Products > Signaling Pathways > HSV | Products > Signaling Pathways > VZV | Products > Signaling Pathways > CMV | Products > Signaling Pathways > EBV

Product Information

• Catalog No.: HY-N6666
• CAS No.: 24356-66-9
• Molecular Formula: C10H15N5O5
• Molecular Weight: 285.26
• Purity: 99.99%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: ≥ 2.08 mg/mL (7.29 mM); Clear solution
• Availability: In-stock

Source

Original product source